Metharmed 0.2mg Injection
Marketer
Zydus Cadila
Salt Composition
Methylergometrine (0.2mg)
Overview Metharmed 0.2mg Injection
Uterine bleeding following childbirth or termination of pregnancy can be managed with Metharmed 0.2mg Injection. This medication acts on uterine smooth muscle, enhancing contractility (tone, frequency, and strength of contractions) to minimize postpartum hemorrhage. Administration is strictly by a physician intravenously or intramuscularly within a hospital setting; self-injection is prohibited. Dosage and frequency are individualized, determined by the treating physician based on the patient's condition and response. Treatment aims to alleviate symptoms effectively. Common adverse effects include headache, elevated blood pressure, and convulsions. Report any concerning or severe side effects to your doctor promptly; mitigation strategies may be available. Alcohol consumption should be avoided during treatment. Prior to commencing therapy, disclose any history of heart disease or hypertension, and provide a complete list of all concurrently used medications to your doctor, as interactions can impact efficacy or alter the drug's mechanism.
Uses of Metharmed 0.2mg Injection
Hemorrhage postpartum
Major Benefits of Metharmed 0.2mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Metharmed 0.2mg Injection:
- High blood pressure
- Headache
- Seizure
How to use Metharmed 0.2mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Metharmed 0.2mg Injection works:
Metharmed 0.2mg Injection, an ergot derivative, induces prolonged uterine smooth muscle contractions. This vascular constriction effectively manages postpartum hemorrhage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Metharmed 0.2mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyUNSAFE
Administering Metharmed 0.2mg Injection to pregnant individuals poses a substantial risk. Pregnant women should consult their physician before use, as research in both animal and human studies indicates considerable harm to the fetus.
Breast feedingCAUTION
Exercise caution when administering 0.2mg Metharmed Injection to breastfeeding mothers. Discontinue breastfeeding throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingCONSULT YOUR DOCTOR
The effect of Metharmed 0.2mg Injection on driving ability is undetermined. Refrain from driving if you experience any symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Metharmed 0.2mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Metharmed 0.2mg Injection to individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take Metharmed 0.2mg Injection :
NA
Facts to Know About Metharmed 0.2mg Injection
| Label | Value |
|---|---|
| Chemical Type | Ergoline alkaloids |
| Developing Habits | No. |
| Treatment Category | OBSTETRICS AND GYNECOLOGY |
| Actions | Drugs inducing uterine contractions and abortion |
3,018 People bought this recently